撤稿声明：勘误：自然杀伤细胞来源的外泌体miR-3607-3p通过靶向IL-26抑制胰腺癌进展。
Retraction: Corrigendum: Natural killer cell-derived exosomal miR-3607-3p inhibits pancreatic cancer progression by targeting IL-26.
出版信息
Front Immunol. 2024 Aug 19;15:1480131. doi: 10.3389/fimmu.2024.1480131. eCollection 2024.
Abstract
[This retracts the article DOI: 10.3389/fimmu.2020.00277.].
摘要
[本文撤回文章DOI：10.3389/fimmu.2020.00277。]
相似文献
1
Retraction: Corrigendum: Natural killer cell-derived exosomal miR-3607-3p inhibits pancreatic cancer progression by targeting IL-26.撤稿声明：勘误：自然杀伤细胞来源的外泌体miR-3607-3p通过靶向IL-26抑制胰腺癌进展。
Front Immunol. 2024 Aug 19;15:1480131. doi: 10.3389/fimmu.2024.1480131. eCollection 2024.
2
Retraction: Natural killer cell-derived exosomal miR-3607-3p inhibits pancreatic cancer progression by targeting IL-26.撤回声明：自然杀伤细胞衍生的外泌体miR-3607-3p通过靶向IL-26抑制胰腺癌进展。
Front Immunol. 2024 Aug 19;15:1480124. doi: 10.3389/fimmu.2024.1480124. eCollection 2024.
3
Corrigendum: Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26.勘误：自然杀伤细胞来源的外泌体miR-3607-3p通过靶向IL-26抑制胰腺癌进展。
Front Immunol. 2020 Feb 21;11:277. doi: 10.3389/fimmu.2020.00277. eCollection 2020.
4
Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26.自然杀伤细胞衍生的外泌体 miR-3607-3p 通过靶向 IL-26 抑制胰腺癌进展。
Front Immunol. 2019 Dec 11;10:2819. doi: 10.3389/fimmu.2019.02819. eCollection 2019.
5
Retraction: Platelet-derived exosomal microRNA-25-3p inhibits coronary vascular endothelial cell inflammation through Adam10 via the NF-κB signaling pathway in ApoE-/- mice.撤稿声明：在载脂蛋白E基因敲除（ApoE-/-）小鼠中，血小板衍生的外泌体微小RNA-25-3p通过Adam10经核因子κB（NF-κB）信号通路抑制冠状动脉血管内皮细胞炎症。
Front Immunol. 2024 May 14;15:1429708. doi: 10.3389/fimmu.2024.1429708. eCollection 2024.
6
Retraction Notice to: Bone Marrow Mesenchymal Stem Cell-Derived Exosomal MicroRNA-126-3p Inhibits Pancreatic Cancer Development by Targeting ADAM9.撤回通知：骨髓间充质干细胞衍生的外泌体微小RNA-126-3p通过靶向ADAM9抑制胰腺癌发展。
Mol Ther Nucleic Acids. 2022 Aug 22;29:617. doi: 10.1016/j.omtn.2022.08.024. eCollection 2022 Sep 13.
7
Retraction: Exosomal miR-25-3p derived from hypoxia tumor mediates IL-6 secretion and stimulates cell viability and migration in breast cancer.撤稿声明：源自缺氧肿瘤的外泌体miR-25-3p介导白细胞介素-6分泌并刺激乳腺癌细胞的活力和迁移。
RSC Adv. 2021 Feb 3;11(11):6257. doi: 10.1039/d1ra90076e. eCollection 2021 Feb 2.
8
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1.胰腺导管上皮细胞来源的外泌体 miR-485-3p 通过靶向 PAK1 抑制胰腺癌转移。
Chin Med J (Engl). 2022 Oct 5;135(19):2326-2337. doi: 10.1097/CM9.0000000000002154.
9
Bone Marrow Mesenchymal Stem Cell-Derived Exosomal MicroRNA-126-3p Inhibits Pancreatic Cancer Development by Targeting ADAM9.骨髓间充质干细胞衍生的外泌体微小RNA-126-3p通过靶向ADAM9抑制胰腺癌发展。
Mol Ther Nucleic Acids. 2019 Jun 7;16:229-245. doi: 10.1016/j.omtn.2019.02.022. Epub 2019 Mar 1.
10
Retracted Article: Exosomal miR-25-3p derived from hypoxia tumor mediates IL-6 secretion and stimulates cell viability and migration in breast cancer.撤稿文章：缺氧肿瘤来源的外泌体miR-25-3p介导白细胞介素-6分泌并刺激乳腺癌细胞的活力和迁移。
RSC Adv. 2019 Jan 11;9(3):1451-1459. doi: 10.1039/c8ra06750c. eCollection 2019 Jan 9.
Zotero 插件